Alan B. Lancz & Associates, Inc. Angiodynamics Inc Transaction History
Alan B. Lancz & Associates, Inc.
- $98.1 Million
- Q2 2025
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Angiodynamics Inc stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 10,950 shares of ANGO stock, worth $96,798. This represents 0.11% of its overall portfolio holdings.
Number of Shares
10,950
Previous 10,950
-0.0%
Holding current value
$96,798
Previous $102,000
5.88%
% of portfolio
0.11%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding ANGO
# of Institutions
158Shares Held
40.6MCall Options Held
33.5KPut Options Held
19.6K-
Black Rock Inc. New York, NY4.6MShares$40.7 Million0.0% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL3.4MShares$30 Million3.05% of portfolio
-
Systematic Financial Management LP Teaneck, NJ2.51MShares$22.2 Million0.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$22 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.95MShares$17.2 Million0.04% of portfolio
About ANGIODYNAMICS INC
- Ticker ANGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 39,107,800
- Market Cap $346M
- Description
- AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...